A process where a researcher or organization plans and then executes a series of steps intended to increase the field of healthcare-related knowledge. This includes studies of safety, efficacy, comparative effectiveness and other information about medications, devices, therapies and other interventional and investigative techniques. ResearchStudies involve the gathering of information about human or animal subjects.

Need to make sure we encompass public health studies.

Identifiers assigned to this research study by the sponsor or other systems.

Allows identification of the research study as it is known by various participating systems and in a way that remains consistent across servers.

A short, descriptive user-friendly label for the study.

The set of steps expected to be performed as part of the execution of the study.

A larger research study of which this particular study is a component or step.

Allows breaking a study into components (e.g. by study site) each with their own PI, status, enrollment, etc.

The current state of the study.

Codes categorizing the type of study such as investigational vs. observational, type of blinding, type of randomization, safety vs. efficacy, etc.

The condition(s), medication(s), food(s), therapy(ies), device(s) or other concerns or interventions that the study is seeking to gain more information about.

Contact details to assist a user in learning more about or engaging with the study.

Citations, references and other related documents.

Key terms to aid in searching for or filtering the study.

Indicates a country, state or other region where the study is taking place.

A full description of how the study is being conducted.

Reference to a Group that defines the criteria for and quantity of subjects participating in the study. E.g. " 200 female Europeans between the ages of 20 and 45 with early onset diabetes".

The Group referenced should not generally enumerate specific subjects. Subjects will be linked to the study using the ResearchSubject resource.

Identifies the start date and the expected (or actual, depending on status) end date for the study.

[The list of types may be constrained as appropriate for the type of event].

The organization responsible for the execution of the study.

Indicates the individual who has primary oversite of the execution of the study.

Clinic, hospital or other healthcare location that is participating in the study.

A description and/or code explaining the premature termination of the study.

Comments made about the event by the performer, subject or other participants.

Describes an expected sequence of events for one of the participants of a study. E.g. Exposure to drug A, wash-out, exposure to drug B, wash-out, follow-up.

Unique, human-readable label for this arm of the study.

E.g. Experimental, active comparator, placebo comparator.

A succinct description of the path through the study that would be followed by a subject adhering to this arm.